SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-19-010620
Filing Date
2019-09-12
Accepted
2019-09-12 09:25:21
Documents
15
Period of Report
2019-09-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tgtx-20191231.htm   iXBRL 8-K 31447
2 PRESS RELEASE tgtx_ex991.htm EX-99.1 19688
  Complete submission text file 0001654954-19-010620.txt   175904

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE tgtx-20191231.xsd EX-101.SCH 2979
4 XBRL CALCULATION FILE tgtx-20191231_cal.xml EX-101.CAL 886
5 XBRL DEFINITION FILE tgtx-20191231_def.xml EX-101.DEF 1885
6 XBRL LABEL FILE tgtx-20191231_lab.xml EX-101.LAB 15866
7 XBRL PRESENTATION FILE tgtx-20191231_pre.xml EX-101.PRE 11619
11 EXTRACTED XBRL INSTANCE DOCUMENT tgtx-20191231_htm.xml XML 4315
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32639 | Film No.: 191089630
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences